TrialFrontiers in immunology2024

Evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of SM17 in healthy volunteers: results from pre-clinical models and a first-in-human, randomized, double blinded clinical trial.

Guolin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.